| # | Title | Journal | Year | Citations |
|---|
| 1 | Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas | Cancer | 2009 | 353 |
| 2 | Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's Disease | Journal of Clinical Oncology | 2007 | 236 |
| 3 | FDG-PET and Beyond: Molecular Breast Cancer Imaging | Journal of Clinical Oncology | 2005 | 156 |
| 4 | Prospective Evaluation of 99mTc MDP Scintigraphy, 18F NaF PET/CT, and 18F FDG PET/CT for Detection of Skeletal Metastases | Molecular Imaging and Biology | 2012 | 135 |
| 5 | Pilot Pharmacokinetic and Dosimetric Studies of18F-FPPRGD2: A PET Radiopharmaceutical Agent for Imaging αvβ3Integrin Levels | Radiology | 2011 | 131 |
| 6 | Bone marrow regeneration following large field radiation.Influence of volume, age, dose, and time | Cancer | 1978 | 108 |
| 7 | Novel Strategy for a Cocktail 18F-Fluoride and 18F-FDG PET/CT Scan for Evaluation of Malignancy: Results of the Pilot-Phase Study | Journal of Nuclear Medicine | 2009 | 105 |
| 8 | The interpretation of 131I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings | Nuclear Medicine Communications | 2003 | 101 |
| 9 | Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis | European Journal of Nuclear Medicine and Molecular Imaging | 1999 | 97 |
| 10 | The indications for and limitations of bone scintigraphy in osteogenic sarcoma: A review of 55 patients | Cancer | 1981 | 89 |
| 11 | Detection of focal hypoxic-ischemic injury and neuronal stress in a rodent model of unilateral MCA occlusion/reperfusion using radiolabeled annexin V | European Journal of Nuclear Medicine and Molecular Imaging | 2004 | 78 |
| 12 | Automatic registration and alignment on a template of cardiac stress and rest reoriented SPECT images | IEEE Transactions on Medical Imaging | 1997 | 76 |
| 13 | Positron emission tomography of the thyroid, with an emphasis on thyroid cancer | Nuclear Medicine Communications | 2001 | 71 |
| 14 | Positron Emission Tomography/Computed Tomography: The Current Technology and Applications | Radiologic Clinics of North America | 2009 | 67 |
| 15 | 2-Deoxy-2-[F-18]fluoro-d-glucose Positron Emission Tomography/Computed Tomography in the Management of Melanoma | Molecular Imaging and Biology | 2007 | 63 |
| 16 | Pilot Prospective Evaluation of 99mTc-MDP Scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and Whole-Body MRI for Detection of Skeletal Metastases | Clinical Nuclear Medicine | 2013 | 61 |
| 17 | Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy | European Journal of Nuclear Medicine and Molecular Imaging | 2012 | 60 |
| 18 | Thyroid Cancer in Pregnant Women: Diagnostic and Therapeutic Management | Thyroid | 1994 | 56 |
| 19 | 18F-FDG PET/CT evaluation of patients with ovarian carcinoma | Nuclear Medicine Communications | 2008 | 55 |
| 20 | Imaging Tumor Angiogenesis: The Road to Clinical Utility | American Journal of Roentgenology | 2013 | 55 |
| 21 | Combined 18F-Fluoride and 18F-FDG PET/CT Scanning for Evaluation of Malignancy: Results of an International Multicenter Trial | Journal of Nuclear Medicine | 2013 | 52 |
| 22 | F-18 FDG PET/CT Evaluation of Osseous and Soft Tissue Sarcomas | Clinical Nuclear Medicine | 2006 | 46 |
| 23 | Merkel Cell Carcinoma: Is there a Role for 2-Deoxy-2-[F-18]fluoro-d-glucose-Positron Emission Tomography/Computed Tomography? | Molecular Imaging and Biology | 2006 | 46 |
| 24 | Clinical value of including the head and lower extremities in 18F-FDG PET/CT imaging for patients with malignant melanoma | Nuclear Medicine Communications | 2007 | 44 |
| 25 | Nitroimidazoles for imaging hypoxic myocardium | Journal of Nuclear Cardiology | 1995 | 39 |
| 26 | Comparison of the clearance of radiolabelled nose drops and nasal spray as mucosally delivered vaccine | Nuclear Medicine Communications | 1999 | 39 |
| 27 | Recombinant human thyrotropin in the management of thyroid cancer | Current Opinion in Oncology | 2001 | 39 |
| 28 | 90Y-Ibritumomab Therapy in Refractory Non-Hodgkin's Lymphoma: Observations from 111In-Ibritumomab Pretreatment Imaging | Journal of Nuclear Medicine | 2008 | 38 |
| 29 | PET/CT Imaging of Thyroid Cancer | Clinical Nuclear Medicine | 2011 | 35 |
| 30 | What is the role of 1100 MBq (< 30 mCi) radioiodine 131I in the treatment of patients with differentiated thyroid cancer? | Nuclear Medicine Communications | 1996 | 34 |
| 31 | Multiple-Radionuclide Autoradiography in Evaluation of Cerebral Function | Journal of Cerebral Blood Flow and Metabolism | 1984 | 31 |
| 32 | 131I-Tositumomab (Bexxar®) vs. 90Y-Ibritumomab (Zevalin®) Therapy of Low-Grade Refractory/Relapsed Non-Hodgkin Lymphoma | Molecular Imaging and Biology | 2010 | 31 |
| 33 | Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer | Nuclear Medicine Communications | 2000 | 30 |
| 34 | Biological Activity of Autoantibodies Associated with Graves' Dermopathy* | Journal of Clinical Endocrinology and Metabolism | 1989 | 28 |
| 35 | Recurrent Silent Thyroiditis: A Report of Four Patients and Review of the Literature | Thyroid | 2007 | 28 |
| 36 | Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma | Journal of Nuclear Medicine | 2007 | 23 |
| 37 | Hypothyroid women need more thyroxine when pregnant | Journal of Family Practice | 1995 | 22 |
| 38 | Automatic registration and alignment on a template of cardiac stress and rest SPECT images | | 1996 | 20 |
| 39 | Selective, Symmetric, Skeletal Muscle Uptake of Tc-99m Pyrophosphate in Rhabdomyolysis | Clinical Nuclear Medicine | 1985 | 18 |
| 40 | Increased cerebral blood flow in MELAS shown by Tc-99m HMPAO brain SPECT | Neuroradiology | 2000 | 18 |
| 41 | Single-Center Prospective Evaluation of 68Ga-PSMA-11 PET in Biochemical Recurrence of Prostate Cancer | American Journal of Roentgenology | 2019 | 18 |
| 42 | Whole-body scanning with radionuclides of iodine, and the controversy of ???thyroid stunning??? | Nuclear Medicine Communications | 2004 | 17 |
| 43 | Evaluation by 18F-FDG-PET of patients with anal squamous cell carcinoma | Hellenic Journal of Nuclear Medicine | 2009 | 17 |
| 44 | New Thoughts about the Cause and Treatment of the Severe Ocular Manifestations of Graves' Disease | Scottish Medical Journal | 1974 | 15 |
| 45 | 111indium bone marrow scintigraphy as an aid in selecting marrow biopsy sites for the evaluation of marrow elements in patients with lymphoma | Cancer | 1976 | 14 |
| 46 | Management of thyroglobulin positive/whole-body scan negative: Is Tg positive/131 I therapy useful? | Journal of Endocrinological Investigation | 2001 | 14 |
| 47 | Current Concepts and Future Directions in Radioimmunotherapy | Current Drug Discovery Technologies | 2010 | 14 |
| 48 | Should a Woman Taking Propylthiouracil Breast-feed? | Clinical Nuclear Medicine | 1986 | 13 |
| 49 | Systemic radiation therapy with unsealed radionuclides | Seminars in Radiation Oncology | 2000 | 13 |
| 50 | F-18 FDG PET/CT Demonstration of an Adrenal Metastasis in a Patient With Anaplastic Thyroid Cancer | Clinical Nuclear Medicine | 2007 | 13 |
